Moving Beyond the 'One Disease, One Drug' Paradigm to Navigate Neurodegenerative ...
Expert Insights: Innovative Discovery Strategies for Proteinopathies
Scientific poster: Evaluation of human iPSC derived triculture as in vitro model for ...
Scientific poster: Development of a robust and scalable iPSC platform for ...
Scientific poster: Development and characterization on human iPSC-derived 3D ...
Scientific poster: Development of robust iPSC-based a-Synuclein, TAU and TDP-43 ...
Research highlights: Shedding Light on Lung Regenerative Medicine
Expert Insights: how to mitigate risk and be successful in neurodegenerative drug ...
Expert Insights: The Crucial Role of QA in Drug Discovery and Development
Case Study: Enabling tissue engineering through robust process development and ...
Mastering Consistency and Quality in iPSC-Derived Cell Manufacturing to Propel ...
Webinar: Transforming Gene Therapy with human in vitro models
Webinar: Beyond Symptom Relief - the Promising Future of NDD Drug Development with ...
Webinar: Alternative preclinical models to revolutionize cardiac and CNS drug ...
Webinar: Unlocking the secrets of muscular disease using iPSC models
Webinar: Human iPSC added value to the drug discovery pipeline
Webinar: iPSCs in gene therapy: Potent Solutions
Science, Innovation and Hope: How to advance drug discovery for neurodegenerative ...
Webinar: iPSC-based 3D microtissues and their applications in drug discovery
Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety ...
Development of next generation of high-tech equipment for cell culture applications.
Press release: Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial ...
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy ...
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the ...
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals ...
Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses ...
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC ...
Press release: Cell & gene therapy accelerator to de-risk early stage research
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
